Moderna, Inc.
NASDAQ: MRNA0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Stéphane Bancel
- Employees
- 5,800
- Headquarters
- Cambridge, United States
- IPO year
- 2018
- Market cap
- $25.4B
- Website
- https://www.modernatx.com
Loading MRNA…
Loading profile data…Frequently asked questions about MRNA
What does Moderna, Inc. (MRNA) do?
Moderna, Inc., a biotechnology firm, is dedicated to the discovery, development, and commercialization of messenger RNA (mRNA) based therapies and preventive medicines. Its extensive research and development efforts target a broad spectrum of medical needs, including infectious diseases, cancer immunology, rare conditions, cardiovascular ailment...
Where does MRNA trade?
Moderna, Inc. (MRNA) trades on the NASDAQ Global Select.
What sector is MRNA in?
Moderna, Inc. (MRNA) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Moderna, Inc.?
Stéphane Bancel is the chief executive officer of Moderna, Inc. (MRNA).
Where is Moderna, Inc. headquartered?
Moderna, Inc. is headquartered in United States.
Does MRNA pay a dividend?
Moderna, Inc. (MRNA) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did MRNA go public?
Moderna, Inc. (MRNA) completed its initial public offering in 2018.